A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma
- 378 Downloads
The molecular mechanisms that control metastasis of hepatocellular cancer (HCC) are still poorly understood. It has been determined that microRNA (miRNA) expression has tissue and cell specific, and decreased expression of specific miRNA could induce tumor genesis or metastasis. In this study, we identified that miR-17-5p was expressed lower in high metastatic capability HCC cell lines HCCLM3 and MHCC97H than low metastatic HCC cell line HepG2 by real-time (RT)-PCR. Restoration of miR-17-5p could significantly repress the invasiveness and metastasis of MHCC97H cell line. Furthermore, we validated c-Myc as a downstream and functional target of miR-17-5p using luciferase reporter assay. Immunohistochemical assay revealed that the expression of c-Myc protein levels was significantly increased in cancerous tissues compared with para-tumor tissues. After clinical data analysis, we observed that the higher level of c-Myc was significantly associated with a reduced overall survival (p = 0.0209). Consistent with previous research, we also demonstrated that c-Myc could upregulate the expression of miR-17-5p. Taken together, our data indicated that there is a regulatory feedback loop between miR-17-5p and c-Myc, in which miR-17-5p could suppress some of the distinguishing features, invasion, and metastasis, of oncogenic c-Myc in HCC cells, and meanwhile, miR-17-5p is upregulated by c-Myc role as a transcription factor, although further studies are still needed.
KeywordsHepatocellular carcinoma (HCC) miR-17-5p c-Myc Regulatory feedback loop Metastasis Invasion
The project was jointly supported by the National Science Foundation of China (81272437, 81472675).
Compliance with ethical standards
All procedures were approved by the Zhongshan Hospital Research Ethics Committee. Informed consent was obtained from each patient according to regulations set forth by the Ethics Committee.
Conflicts of interest
DL Liu, LL Dong, and WZ Wu conceived and designed the study. DL Liu, LL Dong, Y Liu, and D Wen performed the experiments including IHC, RT-PCR, Western blotting and in vivo assays. DL Liu and LL Dong performed luciferase reporter assays. DL Liu, LL Dong, and WZ Wu analyzed the data and prepared the manuscript. DM Gao, HC Sun, and J Fan participated in the study design. All authors read and approved the final manuscript.
- 13.Blancato J, Singh B, Liu A, Liao DJ, Dickson RB. Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br J Cancer. 2004;90(8):1612–9. doi: 10.1038/sj.bjc.6601703.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.El Tayebi HM, Omar K, Hegy S, El Maghrabi M, El Brolosy M, Hosny KA, et al. Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern. Biochem Biophys Res Commun. 2013;434(3):421–7. doi: 10.1016/j.bbrc.2013.04.003.CrossRefPubMedGoogle Scholar
- 26.Sun FX, Tang ZY, Lui KD, Ye SL, Xue Q, Gao DM, et al. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer J Int Du Cancer. 1996;66(2):239–43. doi: 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7.CrossRefGoogle Scholar
- 27.Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol. 2003;129(1):43–51. doi: 10.1007/s00432-002-0396-4.PubMedGoogle Scholar
- 32.Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(16):2707–16. doi: 10.1200/JCO.2007.15.6521.CrossRefGoogle Scholar
- 36.Berg T, Cohen SB, Desharnais J, Sonderegger C, Maslyar DJ, Goldberg J, et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc Natl Acad Sci U S A. 2002;99(6):3830–5. doi: 10.1073/pnas.062036999.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O’Day E, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to “seedless” 3′UTR microRNA recognition elements. Mol Cell. 2009;35(5):610–25. doi: 10.1016/j.molcel.2009.08.020.CrossRefPubMedPubMedCentralGoogle Scholar